High-Throughput Antiviral Assays

Antiviral assays are critical for the rapid and effective response to emerging viral threats. Our high-throughput approach allows greater capacity to identify and characterize large numbers of compounds with known and potential antiviral activity.

SR-Vivarium-Hero-2

Pandemic Preparedness

High-throughput Approach

Southern Research has a history of supporting drug discovery for infectious disease. We have developed a suite of high-throughput cell-based assays measuring physiologically relevant phenotypes such as cytopathic effect and virus levels. Our 96-well human airway epithelial (HAE) model for respiratory viruses is a unique offering allowing a no-compromise solution for programs in influenza, RSV, coronavirus, and HMPV. Whether screening to identify hits or more fully characterizing leads, we can support your high-throughput discovery needs.

 

 

SP-HTS-Paige-Vinson-With-Andrew-Reece-08

Review Our HAE Assays

Learn More
SR-Antiviral-Assay-Image-3

Learn More About Our HAE Assays

View Poster
SP-HTS-Andrew-Reece-08

Review Our Antiviral Assay List

Download Our One Pager
SR-Antiviral-Assay-Image-2

Our Perspective on the Pandemic

Learn More

Our Expert

Paige N. Vinson, Ph.D.

Director, High-Throughput Screening

Partner With Us

Let us be your trusted partner in accelerating your drug discovery journey. Our comprehensive high-throughput discovery services, combined with our unwavering commitment to quality and collaboration, make us the ideal partner to help you identify promising drug candidates faster, unlock the potential of your research, and bring innovative therapies to patients sooner.